(Q35538659)

8 August 2017

1 reference

title

Mining the complexities of the estrogen signaling pathways for novel therapeutics (English)

1 reference

https://api.crossref.org/works/10.1210/EN.2003-0900

8 August 2017

Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics (English)

1 reference

12 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-0900

12 March 2024

author name string

Donald P. McDonnell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500558

reference URL

12 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

published in

Endocrinology

1 reference

8 August 2017

volume

144

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

4237-4240

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

8 August 2017

cites work

https://api.crossref.org/works/10.1210/EN.2003-0900

1

1 reference

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

2

1 reference

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

3

1 reference

Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

4

1 reference

Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

5

1 reference

Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

6

1 reference

Cloning of a novel receptor expressed in rat prostate and ovary

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

8

1 reference

Estrogen receptor null mice: what have we learned and where will they lead us?

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

9

1 reference

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

10

1 reference

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

11

1 reference

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

12

1 reference

The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

13

1 reference

The Molecular Pharmacology of SERMs

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

14

1 reference

An issue of tissues: divining the split personalities of selective estrogen receptor modulators

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

15

1 reference

Connections and regulation of the human estrogen receptor

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

16

1 reference

Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

18

1 reference

Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

19

1 reference

Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

21

1 reference

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

22

1 reference

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

23

1 reference

Definition of the critical cellular components which distinguish between hormone and antihormone activated progesterone receptor.

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

24

1 reference

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

25

1 reference

Peptide antagonists of the human estrogen receptor

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

26

1 reference

Molecular basis of agonism and antagonism in the oestrogen receptor

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

27

1 reference

Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

29

1 reference

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

31

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

32

1 reference

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

33

1 reference

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth

12 March 2024

https://api.crossref.org/works/10.1210/EN.2003-0900

34

1 reference

12 March 2024

Identifiers

DOI

10.1210/EN.2003-0900

1 reference

release_5ka2dacbzfbvfkmweirvqmgnda

8 August 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/5ka2dacbzfbvfkmweirvqmgnda

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference